June 25, 2026 - 01:22

SkyWater Technology, Inc. (SKYT) saw its shares fall sharply in the latest trading session, closing at $35.05. That marked a decline of 4.05% from the previous day's close, a drop that outpaced the broader market indexes. For context, the S&P 500 slipped by a smaller margin during the same period, while the tech-heavy Nasdaq also posted a more modest loss.
The move lower comes amid a broader pullback in semiconductor and specialty manufacturing stocks, though SkyWater's decline was notably steeper than many of its peers. Investors appeared to react to ongoing uncertainty in the chip sector, including shifting demand for advanced packaging and government-funded domestic production initiatives. SkyWater, which operates as a pure-play semiconductor foundry focused on American manufacturing, has been a closely watched name in the push to onshore chip production.
Trading volume for the session was higher than average, suggesting active repositioning by institutional and retail traders alike. While the company has not issued any specific news or guidance changes in the past 24 hours, the price action reflects a cautious mood on Wall Street regarding near-term growth prospects for smaller foundries. Analysts remain split on the stock's valuation, with some pointing to long-term government contracts as a buffer against short-term volatility.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...